Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin

Nature Medicine

Volumn 22, Issue 5, 2016, Pages 524-530

  Kim, Donghyun ^a   Kim, Yun Gi ^a   Seo, Sang Uk ^a   Kim, Dong Jae ^a   Kamada, Nobuhiko ^a   Prescott, Dave ^b   Philpott, Dana J ^b   Rosenstiel, Philip ^c   Inohara, Naohiro ^a   Núñez, Gabriel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHOLERA TOXIN; CYCLIC AMP; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G; PROTEIN; RIPK2 PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARD15 PROTEIN, MOUSE; CYTOKINE; IMMUNOLOGICAL ADJUVANT; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; IMMUNIZATION; MICROFLORA; MOLECULAR RECOGNITION; MOUSE; MUCOSA; NONHUMAN; OLIGOMERIZATION; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS SCIURI; AGONISTS; ANIMAL; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GERMFREE ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MUCOSAL IMMUNITY; NOSE MUCOSA; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD11C; CHOLERA TOXIN; CYCLIC AMP; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GERM-FREE LIFE; IMMUNITY, MUCOSAL; MICE; MICE, KNOCKOUT; MICROBIOTA; MUCOUS MEMBRANE; NASAL MUCOSA; NOD2 SIGNALING ADAPTOR PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84963625248     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4075     Document Type: Article

References (53)

1. Freytag, L.C. & Clements, J.D. Mucosal adjuvants. Vaccine 23, 1804-1813 (2005).
2. Elson, C.O. & Ealding, W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-2741 (1984).
3. Porgador, A., Staats, H.F., Itoh, Y. & Kelsall, B.L. Intranasal immunization with cytotoxic T lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal-mucosa-associated lymphoid tissue. Infect. Immun. 66, 5876-5881 (1998).
4. sα with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 272, 22265-22271 (1997).
5. Lycke, N., Tsuji, T. & Holmgren, J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22, 2277-2281 (1992).
6. Williamson, E., Westrich, G.M. & Viney, J.L. Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol. 163, 3668-3675 (1999).
7. H17 cells and protects against inhalation anthrax. Proc. Natl. Acad. Sci. USA 107, 10638-10643 (2010).
8. Braun, M.C., He, J., Wu, C.Y. & Kelsall, B.L. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1 and β2 chain expression. J. Exp. Med. 189, 541-552 (1999).
9. H2 cells in mucosa-associated tissues. J. Exp. Med. 178, 1309-1320 (1993).
10. H2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94, 5267-5272 (1997).
11. + dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med. 206, 1227-1235 (2009).
12. H subsets. J. Clin. Invest. 122, 963-973 (2012).
13. + DCs. Mucosal Immunol. 8, 815-827 (2015).
14. Shaw, M.H., Reimer, T., Kim, Y.G. & Nuñez, G. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol. 20, 377-382 (2008).
15. Inohara, N. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512 (2003).
16. Girardin, S.E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
17. Park, J.H. et al. RICK (RIP2) mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380-2386 (2007).
18. κB activation. EMBO J. 27, 373-383 (2008).
19. Pavot, V. et al. Cutting edge: new chimeric NOD2-TLR2 adjuvant drastically increases vaccine immunogenicity. J. Immunol. 193, 5781-5785 (2014).
20. H2 polarization of antigen-specific immunity. J. Immunol. 181, 7925-7935 (2008).
21. Fritz, J.H. et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26, 445-459 (2007).
22. Allen, E.K. et al. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome 2, 22 (2014).
23. Warner, N. & Núñez, G. MyD88: a critical adaptor protein in innate immunity signal transduction. J. Immunol. 190, 3-4 (2013).
24. Kawai, T. & Akira, S. Toll-like receptors and their cross-talk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
25. Reinhardt, R.L., Liang, H.E. & Locksley, R.M. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10, 385-393 (2009).
26. FH) differentiation. PLoS One 6, e17739 (2011).
27. Karnowski, A. et al. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp. Med. 209, 2049-2064 (2012).
28. de Rooij, J. et al. Epac is a Rap1 guanine-nucleotide exchange factor directly activated by cyclic AMP. Nature 396, 474-477 (1998).
29. Warner, N. et al. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways. Sci. Signal. 6, rs3 (2013).
30. Ivanov, I.I. et al. Specific microbiota direct the differentiation of IL-17-producing T helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008).
31. Shulzhenko, N. et al. Cross-talk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585-1593 (2011).
32. Abt, M.C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170 (2012).
33. Mazmanian, S.K., Round, J.L. & Kasper, D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
34. Ellouz, F., Adam, A., Ciorbaru, R. & Lederer, E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317-1325 (1974).
35. Magalhaes, J.G. et al. Nucleotide-oligomerization-domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. Proc. Natl. Acad. Sci. USA 108, 14896-14901 (2011).
36. H2-driven allergic inflammation. J. Allergy Clin. Immunol. 126, 1284-1293.e10 (2010).
37. + T cells to the T follicular helper (TFH ) cell lineage is induced by IL-12. Immunol. Cell Biol. 87, 590-600 (2009).
38. Schmitt, N. et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31, 158-169 (2009).
39. Jiang, V., Jiang, B., Tate, J., Parashar, U.D. & Patel, M.M. Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccin. 6, 532-542 (2010).
40. Levine, M.M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 8, 129 (2010).
41. Lopman, B.A. et al. Understanding reduced rotavirus vaccine efficacy in low socioeconomic settings. PLoS One 7, e41720 (2012).
42. Grassly, N.C. et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J. Infect. Dis. 200, 794-801 (2009).
43. Johnson, R.A. et al. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin. Vaccine Immunol. 19, 1712-1721 (2012).
44. Leung, D.T. et al. Comparison of memory B cell, antibody-secreting cell and plasma antibody responses in young children, older children and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin. Vaccine Immunol. 18, 1317-1325 (2011).
45. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
46. Korpe, P.S. & Petri, W.A. Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol. Med. 18, 328-336 (2012).
47. Chattha, K.S., Vlasova, A.N., Kandasamy, S., Rajashekara, G. & Saif, L.J. Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 191, 2446-2456 (2013).
48. Oh, J.Z. et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478-492 (2014).
49. Kim, D. et al. Suppression of allergic diarrhea in murine ovalbumin-induced allergic diarrhea model by PG102, a water-soluble extract prepared from Actinidia arguta. Int. Arch. Allergy Immunol. 150, 164-171 (2009).
50. Wu, H.Y., Nguyen, H.H. & Russell, M.W. Nasal lymphoid tissue (NALT) as a mucosal immune-inductive site. Scand. J. Immunol. 46, 506-513 (1997).
51. Franchi, L., Eigenbrod, T. & Núñez, G. Cutting edge: TNF-α mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 183, 792-796 (2009).
52. Hasegawa, M. et al. Transitions in oral and intestinal microflora composition and innate-immune-receptor-dependent stimulation during mouse development. Infect. Immun. 78, 639-650 (2010).
53. Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332-4341 (2010).